ReviewCancers2020

Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Carlo Buonerba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.